Bioaffinity Technologies, Stock Price Prediction
| BIAF Stock | USD 1.24 0.03 2.36% |
Oversold Vs Overbought
41
Oversold | Overbought |
EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.81) | EPS Estimate Next Year (0.60) | Wall Street Target Price 6 | EPS Estimate Current Quarter (0.17) |
Using BioAffinity Technologies, hype-based prediction, you can estimate the value of bioAffinity Technologies, from the perspective of BioAffinity Technologies, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BioAffinity Technologies, to buy its stock at a price that has no basis in reality. In that case, they are not buying BioAffinity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BioAffinity Technologies, after-hype prediction price | USD 1.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BioAffinity |
BioAffinity Technologies, After-Hype Price Prediction Density Analysis
As far as predicting the price of BioAffinity Technologies, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioAffinity Technologies, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BioAffinity Technologies,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BioAffinity Technologies, Estimiated After-Hype Price Volatility
In the context of predicting BioAffinity Technologies,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioAffinity Technologies,'s historical news coverage. BioAffinity Technologies,'s after-hype downside and upside margins for the prediction period are 0.06 and 8.48, respectively. We have considered BioAffinity Technologies,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BioAffinity Technologies, is dangerous at this time. Analysis and calculation of next after-hype price of bioAffinity Technologies, is based on 3 months time horizon.
BioAffinity Technologies, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BioAffinity Technologies, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioAffinity Technologies, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioAffinity Technologies,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 7.25 | 0.04 | 0.00 | 5 Events / Month | 4 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.24 | 1.29 | 4.03 |
|
BioAffinity Technologies, Hype Timeline
bioAffinity Technologies, is currently traded for 1.24. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.0. BioAffinity is forecasted to increase in value after the next headline, with the price projected to jump to 1.29 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 4.03%, whereas the daily expected return is currently at -0.22%. The volatility of related hype on BioAffinity Technologies, is about 241666.67%, with the expected price after the next announcement by competition of 1.24. bioAffinity Technologies, currently holds about 214.4 K in cash with (6.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out BioAffinity Technologies, Basic Forecasting Models to cross-verify your projections.BioAffinity Technologies, Related Hype Analysis
Having access to credible news sources related to BioAffinity Technologies,'s direct competition is more important than ever and may enhance your ability to predict BioAffinity Technologies,'s future price movements. Getting to know how BioAffinity Technologies,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioAffinity Technologies, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IDXG | Interpace Biosciences | 0.00 | 0 per month | 9.49 | 0.12 | 18.81 | (16.19) | 194.90 | |
| INBS | Intelligent Bio Solutions | (0.03) | 8 per month | 6.27 | 0.07 | 12.88 | (10.59) | 40.29 | |
| SQL | SeqLL Inc | 0.01 | 1 per month | 4.49 | 0 | 12.50 | (10.64) | 50.87 | |
| BIOC | Biocept | (0.10) | 3 per month | 0.00 | (0.28) | 9.24 | (15.27) | 66.54 | |
| TTOO | T2 Biosystms | (0.07) | 7 per month | 0.00 | (0.55) | 5.86 | (12.50) | 26.00 | |
| GENE | Genetic Technologies | 0.03 | 4 per month | 0.00 | (0.08) | 3.49 | (3.53) | 11.15 | |
| HTGM | HTG Molecular Diagnostics | (0.06) | 7 per month | 0.00 | (0.12) | 25.00 | (20.00) | 65.45 | |
| GTH | Genetron Holdings | (0.02) | 1 per month | 2.49 | (0.02) | 3.45 | (4.08) | 14.43 | |
| PMD | Psychemedics | 0.02 | 6 per month | 0.54 | (0.09) | 0.87 | (0.87) | 3.46 | |
| PRPO | Precipio | 0.19 | 5 per month | 0.00 | (0.06) | 5.20 | (4.48) | 14.08 |
BioAffinity Technologies, Additional Predictive Modules
Most predictive techniques to examine BioAffinity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioAffinity using various technical indicators. When you analyze BioAffinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BioAffinity Technologies, Predictive Indicators
The successful prediction of BioAffinity Technologies, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as bioAffinity Technologies,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BioAffinity Technologies, based on analysis of BioAffinity Technologies, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BioAffinity Technologies,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BioAffinity Technologies,'s related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.0209 | 0.001353 | 2.88 | 3.02 | Days Of Inventory On Hand | 5.4K | 4.3K | 3.88 | 3.68 |
Story Coverage note for BioAffinity Technologies,
The number of cover stories for BioAffinity Technologies, depends on current market conditions and BioAffinity Technologies,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioAffinity Technologies, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioAffinity Technologies,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
BioAffinity Technologies, Short Properties
BioAffinity Technologies,'s future price predictability will typically decrease when BioAffinity Technologies,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of bioAffinity Technologies, often depends not only on the future outlook of the potential BioAffinity Technologies,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioAffinity Technologies,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.7 M | |
| Cash And Short Term Investments | 2.8 M |
Complementary Tools for BioAffinity Stock analysis
When running BioAffinity Technologies,'s price analysis, check to measure BioAffinity Technologies,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies, is operating at the current time. Most of BioAffinity Technologies,'s value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies,'s price. Additionally, you may evaluate how the addition of BioAffinity Technologies, to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |